Comorbidity and disease activity in MS on: September 19, 2024, 10:41:40 am #1 From MedPage Today (September 19, 2024)--"Higher comorbidity burden in multiple sclerosis tied to worse outcomes": Higher Comorbidity Burden in Multiple Sclerosis Tied to Worse Outcomes Analysis looks at pooled data of 17,000 MS trial participants bit.ly This research is abstracted in PubMed (9/19/24)--"Comorbidity and disease activity in MS": Comorbidity and Disease Activity in Multiple Sclerosis - PubMed In this study, a higher burden of comorbidity was associated with worse clinical outcomes in people with MS, although comorbidity could potentially be a partial mediator of other negative prognosti... PubMed · pubmed.ncbi.nlm.nih.gov Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
